Valeant avoids double-digit price hikes with 9.9 percent increases

(By Ed Silverman for STAT)

In response to intensifying criticism over drug prices, Allergan chief executive Brent Saunders promised¹ not to raise prices by more than single-digit percentage points. So far, no other head of a large drug maker has spoken publicly about this notion or agreed to do the same thing. Continue reading article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.